ID

21388

Descripción

NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: ABC-Containing Product Discontinuation Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Palabras clave

Versiones (1)
  1. 19/4/17 19/4/17 -
Subido en

19 de abril de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Genetic Screening For HLA-B*5701 in Patients with HIV ABC-Containing Product Discontinuation NCT00340080

Inglés

Genetic Screening For HLA-B*5701 ABC-Containing Product Discontinuation NCT00340080

1 formularios  
ABC-Containing Product Discontinuation
Descripción

ABC-Containing Product Discontinuation

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0663655
UMLS CUI-3
C0850893
Subject Identifier
Descripción

Subject Identifier

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Ziagen:
Descripción

Ziagen stopped

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0724476
UMLS CUI [1,2]
C0850893
Primary reason the ABC-Containing Product was stopped, Ziagen:
Descripción

If Yes, 􏰀check the primary reason the ABC-Containing Product was stopped

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0724476
Primary reason the ABC-Containing Product was stopped, Ziagen:
Descripción

If Other, please specify

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0724476
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Trizivir:
Descripción

Trizivir stopped

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0939514
UMLS CUI [1,2]
C0850893
Primary reason the ABC-Containing Product was stopped, Trizivir:
Descripción

primary reason Trizivir was stopped

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0939514
Primary reason the ABC-Containing Product was stopped, Trizivir:
Descripción

If Other, please specify

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0939514
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Kivexa:
Descripción

Kivexa stopped

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1567988
UMLS CUI [1,2]
C0850893
Primary reason the ABC-Containing Product was stopped, Kivexa:
Descripción

primary reason Kivexa was stopped

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C1567988
Primary reason the ABC-Containing Product was stopped, Kivexa:
Descripción

If Other, please specify

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C1567988
Volver a la parte superior de la página

Similar models

Genetic Screening For HLA-B*5701 ABC-Containing Product Discontinuation NCT00340080

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
ABC-Containing Product Discontinuation
C0013227 (UMLS CUI-1)
C0663655 (UMLS CUI-2)
C0850893 (UMLS CUI-3)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Ziagen:
text
C0724476 (UMLS CUI [1,1])
C0850893 (UMLS CUI [1,2])
ABC-Containing product stopped
Code List
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Ziagen:
CL Item
Yes (Y)
CL Item
No (N)
Item
Primary reason the ABC-Containing Product was stopped, Ziagen:
integer
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
primary reason the ABC-Containing Product was stopped
Code List
Primary reason the ABC-Containing Product was stopped, Ziagen:
CL Item
Adverse event (Record details on the Non-Serious Adverse Events or Serious Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Investigator Decision (26)
CL Item
Other, specify (0)
primary reason Ziagen was stopped
Item
Primary reason the ABC-Containing Product was stopped, Ziagen:
text
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
Item
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Trizivir:
text
C0939514 (UMLS CUI [1,1])
C0850893 (UMLS CUI [1,2])
ABC-Containing product stopped
Code List
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Trizivir:
CL Item
Yes (Y)
CL Item
No (N)
Item
Primary reason the ABC-Containing Product was stopped, Trizivir:
integer
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
primary reason the ABC-Containing Product was stopped
Code List
Primary reason the ABC-Containing Product was stopped, Trizivir:
CL Item
Adverse event (Record details on the Non-Serious Adverse Events or Serious Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Investigator Decision (26)
CL Item
Other, specify (0)
primary reason Trizivir was stopped
Item
Primary reason the ABC-Containing Product was stopped, Trizivir:
text
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
Item
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Kivexa:
text
C1567988 (UMLS CUI [1,1])
C0850893 (UMLS CUI [1,2])
ABC-Containing product stopped
Code List
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Kivexa:
CL Item
Yes (Y)
CL Item
No (N)
Item
Primary reason the ABC-Containing Product was stopped, Kivexa:
integer
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
primary reason the ABC-Containing Product was stopped
Code List
Primary reason the ABC-Containing Product was stopped, Kivexa:
CL Item
Adverse event (Record details on the Non-Serious Adverse Events or Serious Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Investigator Decision (26)
CL Item
Other, specify (0)
primary reason Kivexa was stopped
Item
Primary reason the ABC-Containing Product was stopped, Kivexa:
text
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial